These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4364446)

  • 1. [Characteristics of the serological properties of Bordetella pertussis variants with defective cell walls].
    Lapaeva IA; Shirko GN; Zakharova MS
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Apr; 51(4):23-7. PubMed ID: 4364446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Localization of toxic substances in microbial variants of B. pertussis with defective cell walls].
    Lapaeva IA; Shirko GN; Pereverzev NA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Oct; (10):7-12. PubMed ID: 4375921
    [No Abstract]   [Full Text] [Related]  

  • 3. [The kinetics of the formation and morphology of B. pertussis spheroplasts].
    Shirko GN; Zakharova MS; Lapaeva IA; Pereverzev NA
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):85-8. PubMed ID: 4337417
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serotype and drug susceptibility of Bordetella pertussis and Bordetella parapertussis isolated from 1975 to 1985 in Japan].
    Watanabe M; Haraguchi Y; Gonda T; Aoyama T; Ozawa H; Murase Y; Iwata T; Iwata S; Kusano S
    Kansenshogaku Zasshi; 1987 Jan; 61(1):79-86. PubMed ID: 2883241
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serological types of strains of B. pertussis isolated in the Warsaw area and evaluation of their histamine-sensitisation potential for mice].
    Kuklińska-Miszczyk D; Kopacka B
    Med Dosw Mikrobiol; 1969; 21(3):255-63. PubMed ID: 4311281
    [No Abstract]   [Full Text] [Related]  

  • 6. Serotype and drug susceptibility of Bordetella pertussis isolated in Japan from 1975 to 1984.
    Watanabe M; Nakase Y; Aoyama T; Ozawa H; Murase Y; Iwata T
    Microbiol Immunol; 1986; 30(5):491-4. PubMed ID: 2875381
    [No Abstract]   [Full Text] [Related]  

  • 7. Areexamination of phase IV Bordetella pertussis.
    Aprile MA
    Can J Microbiol; 1972 Dec; 18(12):1793-801. PubMed ID: 4346447
    [No Abstract]   [Full Text] [Related]  

  • 8. [The fine structure of glycin-induced spheroplasts compared to that of normal bacterial cells of Bordetella pertussis].
    Milleck J; Rockstroh T; Ocklitz HW
    Zentralbl Bakteriol Orig; 1968; 209(1):37-43. PubMed ID: 4317773
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotyping Bordetella pertussis strains.
    Robinson A; Ashworth LA; Irons LI
    Vaccine; 1989 Dec; 7(6):491-4. PubMed ID: 2575308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of Bordetella pertussis in the Ribi cell fractionator. 2. Effect of different suspending media.
    Hollinger E; Wardlaw AC
    Can J Microbiol; 1971 Sep; 17(9):1195-202. PubMed ID: 4107161
    [No Abstract]   [Full Text] [Related]  

  • 11. The antibacterial effect of Bordetella pertussis antisera.
    Dolby JM
    Immunology; 1965 May; 8(5):484-98. PubMed ID: 4284285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of ethylenediaminetetraacetic acid, tris(hydroxymethyl)-aminomethane, and lysozyme on cell walls of Pseudomonas aeruginosa.
    Cox ST; Eagon RG
    Can J Microbiol; 1968 Aug; 14(8):913-22. PubMed ID: 4969992
    [No Abstract]   [Full Text] [Related]  

  • 13. Turbidimetric study of the action of surface active agents on isolated cell walls of Vibrio cholerae.
    Sur P; Chatterjee SN
    Indian J Exp Biol; 1972 May; 10(3):205-7. PubMed ID: 4631236
    [No Abstract]   [Full Text] [Related]  

  • 14. [Circulation of pertussis bacteria of different serological types in some districts of the USSR].
    Demina AA; Larina LI; Kostiukova KP; Kolotilova LV; Kurilenko EI
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Nov; 47(11):22-7. PubMed ID: 4323570
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antigenic structure of B. pertussis and its relation to conditions of circulation. I. Serotyping of pertussis cultures and study of its determining factors].
    Kuznetsov EA
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Sep; 49(9):122-7. PubMed ID: 4347171
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth and siderophore production by Bordetella pertussis under iron-restricted conditions.
    Gorringe AR; Woods G; Robinson A
    FEMS Microbiol Lett; 1990 Jan; 54(1-3):101-5. PubMed ID: 2138989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of agglutinin production in mice in the determination of the definitive serotype of Bordetella pertussis.
    Bronne-Shanbury CJ
    J Hyg (Lond); 1976 Apr; 76(2):257-64. PubMed ID: 177702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cyclodextrin as an agent to induce excretion of Bordetella pertussis antigens.
    Hozbor D; Rodriguez ME; Yantorno O
    FEMS Immunol Med Microbiol; 1994 Aug; 9(2):117-24. PubMed ID: 7804162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bordetella pertussis isolates studied at the National Health Institute, Wellington, between 1977 and 1981.
    Cawley PF
    N Z Med J; 1983 Oct; 96(742):805-6. PubMed ID: 6312385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serology of Bordetella pertussis. I. Distribution of serotypes].
    Mebel S
    Zentralbl Bakteriol Orig; 1968 May; 206(4):481-5. PubMed ID: 4314367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.